Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.

<h4>Background</h4>Patients with chronic lymphocytic leukemia (CLL) experience hypogammaglobinemia and non-neutropenic infections. In this exploratory proof of concept study, our objective was to determine the prevalence of humoral immunodeficiency in patients with CLL and serum IgG ≥ 40...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S Shahzad Mustafa, Saad Jamshed, Karthik Vadamalai, Allison Ramsey
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/83aaece5374945f293bf4275043b9bed
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!